|
DFFA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20570000000853E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.029570E-04 |
| Normal-vs-Stage2 |
4.195300E-03 |
| Normal-vs-Stage3 |
1.71350000000015E-06 |
| Normal-vs-Stage4 |
5.57489999999383E-05 |
| Stage1-vs-Stage2 |
9.846600E-01 |
| Stage1-vs-Stage3 |
1.693750E-01 |
| Stage1-vs-Stage4 |
2.660400E-01 |
| Stage2-vs-Stage3 |
3.595400E-01 |
| Stage2-vs-Stage4 |
4.661600E-01 |
| Stage3-vs-Stage4 |
9.245200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23389999999268E-05 |
| Normal-vs-AfricanAmerican |
9.555900E-02 |
| Normal-vs-Asian |
5.244700E-04 |
| Caucasian-vs-AfricanAmerican |
2.485400E-01 |
| Caucasian-vs-Asian |
7.653000E-01 |
| AfricanAmerican-vs-Asian |
2.024200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.59379999987009E-07 |
| Normal-vs-Female |
5.70890000000102E-05 |
| Male-vs-Female |
4.303900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.184900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.82459999995299E-06 |
| Normal-vs-Age(61-80Yrs) |
1.85065999999123E-05 |
| Normal-vs-Age(81-100Yrs) |
1.402420E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.416200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.797950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.554400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.904600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.454800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.488400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.669400E-01 |
| Classical-VS-Follicular |
2.424600E-03 |
| Classical-VS-Other |
9.466100E-02 |
| Classical-VS-Normal |
2.553000E-04 |
| Tall-VS-Follicular |
3.721000E-01 |
| Tall-VS-Other |
2.604200E-01 |
| Tall-VS-Normal |
8.786300E-04 |
| Follicular-VS-Other |
5.992200E-01 |
| Follicular-VS-Normal |
1.99629999997342E-06 |
| Other-VS-Normal |
5.217700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59841999999299E-05 |
| Normal-vs-N1 |
1.86869999999617E-05 |
| N0-vs-N1 |
2.464200E-01 |
|
|
